Yiqi Yang

1.3k citations
30 papers · 1.0k indexed · 1 hit paper · h-index 17

Yiqi Yang

30 papers receiving 1.0k citations

Hit Papers

Targeting ferroptosis suppresses osteocyte glucolipotoxic...173202220262023202450100150

Peers

Yiqi Yang
Comparison fields: 5 of 101
  • Molecular Medicine 85
  • Rehabilitation 114
  • Microbiology 70
  • Biomedical Engineering 392
  • Cancer Research 112
Replace Mingliang Zhou with:
Mingliang Zhou China
Kai Yuan China
Qi‐Wen Chen China
Xianzuo Zhang China
Mark Boon Yang Tang Singapore
Sonia Kapoor India
Oliver Germershaus Germany
Elia Bari Italy
Jiawei Mei China
Jialu Xu China
Yiqi Yang relative to Mingliang Zhou China Mingliang Zhou's profile →
Citations per field
00.5×2.9×
Mingliang Zhou · 1×
Citations per year

Countries citing papers authored by Yiqi Yang

Since Specialization
Citations

This map shows the geographic impact of Yiqi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiqi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiqi Yang more than expected).

Fields of papers citing papers by Yiqi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiqi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiqi Yang. The network helps show where Yiqi Yang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yiqi Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yiqi Yang Line = papers co-authored together Yiqi Yang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 202512
3 20253
4 202416
5 202313
6 202325
7 202316
8 20238
9 202310
10 20239
11 20231
12 202210
13
Targeting ferroptosis suppresses osteocyte glucolipotoxicity and alleviates diabetic osteoporosisbreakdown →
2022173
14 202218
15 202139
16 202117
17 202024
18 202073
19 202044
20 201418

About Yiqi Yang

Yiqi Yang is a scholar working on Biomedical Engineering, Orthopedics and Sports Medicine and Oncology, having authored 30 papers that have together received 1.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (7 papers), Bone Tissue Engineering Materials (7 papers), 3D Printing in Biomedical Research (5 papers), Advanced Nanomaterials in Catalysis (3 papers), Cancer Cells and Metastasis (3 papers), Titanium Alloys Microstructure and Properties (3 papers), Bone Metabolism and Diseases (3 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Molecular Medicine (85 citations), Rehabilitation (114 citations) and Microbiology (70 citations). Yiqi Yang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Tingting Tang, Shengbing Yang, Minqi Wang, Kai Yuan, Hanjun Li, Yixuan Lin, Qishan Wang, Kai Huang, Zhifeng Yu and Haishuang Chang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Advanced Functional Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026